Ligand to Present at Stifel 2024 Healthcare Conference [Yahoo! Finance]
Ligand to Present at Stifel 2024 Healthcare Conference
iMetabolic Biopharma Receives Second NIH Grant Award for Drug Discovery [Yahoo! Finance]
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) had its price target raised by analysts at Royal Bank of Canada from $130.00 to $140.00. They now have an "outperform" rating on the stock.
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) had its price target raised by analysts at Benchmark Co. from $110.00 to $135.00. They now have a "buy" rating on the stock.